Biorestorative Therapies, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
BioRestorative Therapies, Inc. filed an S-1/A amendment to include a Placement Agency Agreement and a revised filing fee table for its proposed public offering of securities.
NASDAQ
BioRestorative Therapies is offering up to 9.7 million units, aiming to raise $10 million to fund clinical trials and R&D, amidst ongoing substantial losses and going concern doubts.
NASDAQ
BioRestorative Therapies filed a resale S-1 registering 508,592 shares underlying October 2025 warrants, with no proceeds to the company unless warrants are exercised at $2.75.
NASDAQ
BioRestorative Therapies, Inc. files an amendment to its Form S-1 registration statement to include additional exhibits related to its corporate structure, agreements, and legal opinions.
NASDAQ
BioRestorative Therapies has filed a registration statement for the potential resale of up to 2,513,686 shares of its common stock by existing securityholders.